Chronic Kidney Disease
Part of NephTimes
The ASN HDU Home Dialysis Scholarship Program will continue in 2024. A study found that countries in low-resource settings show substantially diminished capacity for kidney care delivery. Humana and Strive Health announced a partnership to provide value-based kidney care to more Medicare Advantage plan members. Kroger has entered into an agreement to sell its specialty pharmacy business to CarelonRx. The home dialysis model is designed to start with peritoneal dialysis and transition to home hemodialysis. The FDA removed two dialysis-related product codes from its device shortage list. The PATIENT Act to provide access to care and affordable oral medicines for CKD is a step closer to becoming law. Researchers studied the association of eGFR and UACR with structural brain abnormalities visible on MRI. Researchers have developed a novel minimally invasive method to deliver drugs directly to the kidney. Vlado Perkovic has not presented the results of the FLOW trial, but the surprise is gone. We know what he is going to say. KDIGO has released its 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. The FDA has granted Fast Track designation DISC-0974 for the treatment of anemia in patients with NDD-CKD. Aetna, in partnership with Monogram Health, will offer in-home care to its Medicare Advantage members with CKD or ESKD. Labs at Sheffield Teaching Hospitals are the first in the UK using AI to determine kidney failure risk. The American Society of Nephrology will receive a $100,000 grant to promote a race-free algorithm to measure eGFR. Researchers studied the association between adolescent BMI and early CKD in young adulthood. Nutrition therapy may help manage the uremic complications associated with cardiovascular risk in those with kidney failure. Anemia associated with CKD can be treated with oral hypoxia-inducible factor prolyl hydroxylase inhibitors. Patients with diabetic kidney disease face increased risk of end-stage kidney disease and dialysis. Serum creatinine-based eGFR (eGFRcr) remains inaccurate and can overestimate eGFR, particularly in patients with sarcopenia.